Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2001
10/17/2001EP1144997A2 Methods and compounds for modulating nuclear receptor activity
10/17/2001EP1144686A2 Genetic predisposition to abnormal calcification conditions
10/17/2001EP1144673A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
10/17/2001EP1144651A1 Polypeptides derived from jnk3
10/17/2001EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001EP1144634A2 Novel complex-forming proteins
10/17/2001EP1144614A2 33 human secreted proteins
10/17/2001EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof
10/17/2001EP1144592A2 Substrate for cell growth
10/17/2001EP1144450A1 Mammalian alpha-helical protein - 12
10/17/2001EP1144443A2 Human membrane transport proteins
10/17/2001EP1144441A2 Disintegrin homologs
10/17/2001EP1144435A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144431A2 16-hydroxyestratrienes as selective estrogens
10/17/2001EP1144426A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
10/17/2001EP1144421A1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
10/17/2001EP1144413A1 2,5-diazabicyclo 2.2.1]heptane derivatives, their preparation and therapeutic uses
10/17/2001EP1144410A2 Use of imidazo 1,5-a]-pyrido 3,2-e]-pyrazinones as medicaments
10/17/2001EP1144409A2 Phenyl urea and phenyl thiourea derivatives
10/17/2001EP1144408A1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application
10/17/2001EP1144405A1 Triazole compounds with dopamine-d3-receptor affinity
10/17/2001EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors
10/17/2001EP1144402A2 Substituted oximes and hydrazones as neurokinin antagonists
10/17/2001EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
10/17/2001EP1144395A1 2-amino-benzoxazinone derivatives for the treatment of obesity
10/17/2001EP1144394A1 1-heterocycle substituted diarylamines
10/17/2001EP1144393A2 Heterocyclic derivatives and their use as integrin inhibitor
10/17/2001EP1144389A1 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoicacid]calcium salt
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
10/17/2001EP1144386A1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
10/17/2001EP1144385A1 Benzoheterocycles and their use as mek inhibitors
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144381A2 Substituted benzo[de]isoquinoline-1,3-diones
10/17/2001EP1144373A2 Serine protease inhibitors
10/17/2001EP1144372A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
10/17/2001EP1144371A1 Benzenesulphonamide derivatives and their use as mek inhibitors
10/17/2001EP1144370A2 Thyroid receptor ligands
10/17/2001EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144362A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
10/17/2001EP1144305A1 NOVEL sPLA 2 INHIBITORS
10/17/2001EP1144050A2 Binding partners for 5-ht5-receptors for the treatment of migraine
10/17/2001EP1144003A1 Methods and devices for delivery of agents to breast milk ducts
10/17/2001EP1143998A2 Treatment of hypertension
10/17/2001EP1143996A2 Method of treating chronic cardiac disease
10/17/2001EP1143988A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
10/17/2001EP1143977A1 2-oxy-benzoxazinone derivatives for the treatment of obesity
10/17/2001EP1143975A1 Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances
10/17/2001EP1143971A1 Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use
10/17/2001EP1143968A2 Composition and methods for administration of water-insoluble paclitaxel derivatives
10/17/2001EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001EP1143964A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
10/17/2001EP1143963A1 Multiparticulate bisoprolol formulation
10/17/2001EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto
10/17/2001EP1143956A2 Compositions and methods for the treatment of anorectal disorders
10/17/2001EP1143955A2 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES
10/17/2001EP1143949A2 19-nor-vitamin d3 compounds with calcemic activity
10/17/2001EP1143947A2 Use of estrogen compounds for prevention and treatment of ischemic damage
10/17/2001EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
10/17/2001EP1143945A2 Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry
10/17/2001EP1143944A2 Use of arylalkanoylpyridazines
10/17/2001EP1143942A2 Use of gaba-b receptor ligands for the treatment of neurodegenerative diseases
10/17/2001EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
10/17/2001EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001EP1143805A2 Methods for reducing mortality rates in poultry
10/17/2001EP0999841B1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
10/17/2001EP0983265A4 Endothelin receptor antagonists
10/17/2001EP0877025B1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
10/17/2001EP0796251B1 Uracil derivatives
10/17/2001EP0641330B1 Gaba and l-glutamic acid analogs for antiseizure treatment
10/17/2001CN1318069A Factor VIIa inhibitors
10/17/2001CN1318058A 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as CRTP inhibitors
10/17/2001CN1318057A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoliines as CETP inhibitors
10/17/2001CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
10/17/2001CN1318054A Novel compounds
10/17/2001CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers
10/17/2001CN1317972A Compsn contg. rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
10/17/2001CN1317970A Method for treating atherosclerosis empolying ap2 inhibitor and combination
10/17/2001CN1317968A 2-bustituted-1-piperidyl benzimidazole compounds as or/1-receptor agonists
10/17/2001CN1317961A Compsn. contg. cinnamic acid derivatives for preventing or treating elevated blood lipid level-releated diseases
10/17/2001CN1317938A Compsn. contg. neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-reated diseases
10/17/2001CN1317937A Compsn. containing natural phenolic compound for preventing or treating elevated blood liquid level-related diseases
10/17/2001CN1317490A Novel-6-sulfamine-3-quinolyl phosphonate compounds, its prepn. process and medical compsn. contg. them
10/17/2001CN1317489A Novel aryl radical or heteroaryl radical quinolyl phosphonate compounds, its preparing method and medical compsn. contg. them
10/17/2001CN1317337A Rehmannia root extract and its preparing process and application
10/17/2001CN1317331A Chinese medicine for treating cerebral arteriosclerosis and its preparing process
10/17/2001CN1317329A Compound artemisia preparation for treating piles and its preparing process
10/17/2001CN1317311A Application of full-trans-tretinoin in preparing medicines to cure myocardial hypertrophy and vessel wall hyperplasia
10/17/2001CN1073154C Superoxide dismutase-4
10/17/2001CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof
10/17/2001CN1073101C Substituted 1,2,3,4-tetrahydronaphthalene derivatives
10/17/2001CN1072936C Medicine for curing cerebrovascular, cardiovascular and peripheral vascular diseases
10/17/2001CN1072934C Pharmaceutical emulsion
10/17/2001CN1072908C Food additive benefiting patients of diabetics, coronary heart disease and tumor
10/17/2001CA2343843A1 Therapeutic light source and method
10/16/2001US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
1 ... 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 ... 1595